DNA blood tests to detect cancer
A technology which identifies disease-specific genetic fingerprints based on DNA fragments that are released into the bloodstream by damaged and dying (apoptotic) cells has been developed by Chronix Biomedical laboratory. DNA blood tests are able to accurately detect early stage breast and prostate cancers.
In their study, Chronix's assays detected and identified DNA fingerprints in the blood that indicated the presence of prostate or breast cancer with 92% sensitivity and 100% specificity, which is far higher than current diagnostic tests.
If this data is confirmed in larger studies, it then has the potential to decrease the rate of false positive and false negative results, which lead to poorer patient outcomes and higher healthcare costs.
© 2007 - 2024 NutritionVista.com. All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. All articles and content written by the Nutritionvista.com team for NutritionVista.com are the sole property of J.L.S Healthcare Pvt. Ltd. Content may not be copied without express permission to do so. If you want to link back to an article, please ensure a working link to the article title is used and is functioning at all times.